MARSHALL WACE, LLP - CEREVEL THERAPEUTICS HLDNG I ownership

Back to all holdings Add to watchlist

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 63 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Links
Filings
External links
Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q1 2021$324,000
-71.2%
23,597
-65.2%
0.00%
-83.3%
Q4 2020$1,124,000–67,772–0.01%–
 Download
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q1 2021
NameSharesValueWeighting ↓
Anchor Investment Management, LLC 100$4,2400.00%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders